Disruption of circadian insulin secretion is associated with reduced glucose uptake in first-degree relatives of patients with type 2 diabetes

Diabetes

Volumn 48, Issue 11, 1999, Pages 2182-2188

  Boden, Guenther ^a,b   Chen, Xinhua ^a   Polansky, Marcia ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RELATIVE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; FAMILY; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN; MALE; PHILADELPHIA; PROINSULIN; REFERENCE VALUES;

EID: 0032710788     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.11.2182     Document Type: Article

References (39)

1. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR: Slow glucose removal rate and hyperinsulinemia precede the development of type 2 diabetes in the offspring of diabetic patients. Ann Intern Med 113:909-915, 1990
2. Barnett AH, Spiliopoulos AJ, Pyke DA, Stubbs WA, Burrin J, Alberti KGMM: Metabolic studies in unaffected co-twins of non-insulin-dependent diabetics. Brit Med J (Clin Res Ed) 282:1656-1658, 1981
3. Rich SS: Mapping genes in diabetes: genetic epidemiological perspective. Diabetes 39:1315-1319, 1990
4. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337-343, 1990
5. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Jarvinen H, Freymond D, Nyomba BL, Zurlo F, Swinbum B, Bogardus C: Impaired glucose tolerance as a disorder of insulin action. N Engl J Med 318:1217-1225, 1988
6. Vaag A, Henriksen JE, Beck-Nielsen H: Decreased insulin activation of glycogen synthase in skeletal muscles in young non-obese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89:782-788, 1992
7. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK: Increased insulin concentrations in nondiabetic offspring of diabetic parents. N Engl J Med 319:1297-1301, 1988
8. Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo RA: The metabolic profile of IDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41:1575-1586, 1992
9. Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, Dailey G, Gerich J: Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM: evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA 273:1855-1861, 1995
10. Boden G, Ruiz J, Urbain J-L, Chen X: Evidence for a circadian rhythm of insulin secretion. Am J Physiol 271:E246-E252, 1996
11. Goodner CJ, Walike BC, Koerker DJ, Ensinck JW, Brown AC, Chideckel EW, Palmer J, Kalnasy L: Insulin, glucagon, and glucose exhibit synchronous sustained oscillations in fasting monkeys. Science 195:177-179, 1977
12. Plat L, Byrne MM, Sturis J, Polonsky KS, Mockel J, Fery F, Van Cauter E: Effects of morning cortisol elevation on insulin secretion and glucose regulation in humans. Am J Physiol 270:E36-E42, 1996
13. Polonsky KS, Given BD, Van Cauter E: Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest 81:442-448, 1988
14. Boden G, Chen X, Urbain JL: Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production. Diabetes 45:1044-1050, 1996
15. Van Cauter E, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377, 1992
16. Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, Frank B: Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type 1 diabetic patients. J Clin Invest 77:98-105, 1986
17. Sonneberg GE, Hoffman RG, Johnson CP, Kissebah AH: Low and high-frequency insulin secretion pulses in normal subjects and pancreas transplant recipients: rate of extrinsic innervation. J Clin Invest 90:545-553, 1986
18. Guide to Statistical and Mathematical Analysis, S-PLUS. Seattle, WA, StatSci Division MathSoft, 1995, p. 17-2-17-3
19. Mosteller F, Tukey JW: Data Analysis and Regression. Reading, MA, Addison Wesley, 1977, p. 356-365
20. Guide to Statistical and Mathematical Analysis, S-PLUS. Seattle, WA, StatSci Division MathSoft, 1995, p. 7-50-7-51
21. Guide to Statistical and Mathematical Analysis, S-PLUS. Seattle, WA, StatSci Division MathSoft, 1995, p. 17-5-17-17
22. Wolfe RR: Tracers in metabolic research. In Radioisotope and Stable Isotope/Mass Spectrometry Methods. New York, Alan R. Liss, 1984, p. 261
23. Steele R, Wall JS, DeBodo RC, Altszuler N: Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187:15-24, 1956
24. Molina JM, Baron AD, Edelman SV, Brechtel G, Wallace P, Olefsky JM: Use of a variable tracer infusion method to determine glucose turnover in humans. Am J Physiol 258:E16-E23, 1990
25. Arendt J: Melatonin. Clin Endocrinol 29:205-209, 1988
26. Cassone V, Warren W, Brooks D, Lu J: Melatonin, the pineal gland and circadian rhythms. J Biol Rhythms 8 (Suppl. 1):S73-S81, 1993
27. Czeisler CA: The effect of light on the human circadian pacemaker. In Ciba Foundation Symposium 183. Chichester, UK, Wiley, 1995, p. 254-302
28. Turek FW: Circadian neural rhythms in mammals. Ann Rev Physiol 47:49-64, 1985
29. O'Rahilly S, Turner RC, Matthews DR: Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 318:1225-1230, 1988
30. Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU: Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Sun Synth Path Res 4:110-125, 1985
31. Stern MP: Type II diabetes mellitus: interface between clinical and epimediological investigation. Diabetes Care 11:119-126, 1988
32. Welsh M, Scherberg N, Gilmore R, Steiner DF: Translational control of insulin biosynthesis: evidence for regulation of elongation, initiation and signal-recognition-particle-mediated translational arrest by glucose. Biochem J 235:459-467, 1986
33. Sobey WJ, Beer SF, Carrington CA, Clark PMS, Frank BH, Gray IP, Luzio SD, Owens DR, Schneider AE, Siddle K, Temple RC, Hales CN: Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 and 32-33 split proinsulin. Biochem J 260:535-541, 1989
34. Kahn SE, Halban PA:. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 46:1725-1732, 1997
35. Haffner SM, Mykkanen L, Valdez RA, Stern MP, Holloway DL, Monterrosa A, Bowsher RR: Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome. J Clin Endocrinol Metab 79:1806-1810, 1994
36. Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, Hales CN: Insulin deficiency in non-insulin-dependent diabetes. Lancet i:293-295, 1989
37. Tillil H, Frank BH, Pekar AH, Broelsch C, Rubenstein AH, Polonsky KS: Hypoglycemic potency and metabolic clearance rate of intravenously administered proinsulin and metabolites. Endocrinology 127:2418-2422, 1990
38. Rossetti L, Giaccari A, DeFronzo RA: Glucose toxicity. Diabetes Care 13:610-630, 1990
39. Boden G, RuizJ, Kim C-J, Chen X: Effects of prolonged glucose infusion on insulin secretion, clearance and action in normal subjects. Am J Physiol (Endocrinol Metab) 270:E251-E258, 1996